about
Macrophage migration inhibitory factorCalreticulinCyclin-dependent kinase 4Checkpoint kinase 2Cyclin D1Macrophage migration inhibitory factor (glycosylation-inhibiting factor)Cyclin-dependent kinase 9 (CDC2-related kinase)Forkhead box E3MDM4 regulator of p53Ras association domain family member 1Frizzled class receptor 9Cyclin KEcotropic viral integration site 2BNuclear protein 2, transcriptional regulatorHigh mobility group nucleosome binding domain 5MLX interacting protein likeHeat shock protein 90 alpha family class B member 1Transcription factor AP-4SET domain and mariner transposase fusion geneProtein Mdm4E3 ubiquitin-protein ligase Mdm2Fibroblast growth factor 10Zinc finger protein 268Transformed mouse 3T3 cell double minute 2G protein-coupled estrogen receptor 1Cyclin-KCalpastatinMLX interacting protein-likeFrizzled class receptor 9Transformed mouse 3T3 cell double minute 460S ribosomal protein L23Forkhead box E3Fibroblast growth factor 10Ecotropic viral integration site 2bHeat shock protein 90 alpha (cytosolic), class B member 1Nuclear protein transcriptional regulator 1 likeRas association (RalGDS/AF-6) domain family member 1Ribosomal protein L23MDM2 proto-oncogeneRibosomal protein L23
P682
Cyclin-dependent kinase 9-cyclin K functions in the replication stress responseDownregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cellsMetnase mediates resistance to topoisomerase II inhibitors in breast cancer cellsARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathwaysFunctional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1
P921
Q133582-20F92FA4-1BA3-4A10-8EAF-669F1DF0636CQ14633944-29CA786F-B38D-4E27-91B5-EE224B47761EQ14911756-3E33C2F3-A0F4-4C81-84B6-1CB058B58C41Q14912285-0C5114B4-8702-4A47-AC10-CDD645A2BE6CQ15311866-D71A058A-1E2B-4AD8-9B38-905D54D55E9AQ15311912-3F268171-AB09-4603-91E0-F7EC9C81A223Q15314958-F2512D88-58E0-4367-9B7C-AB5095799150Q21108599-ADEE874C-8BF7-4043-966E-3CF42F74C91DQ21109171-A46104D6-D8A8-4FC8-AAFE-6579EDDF4613Q21112140-50DE4141-0616-4849-ADD8-A0BE40C9819DQ21115915-A3037140-B06F-47A1-B768-0B1AB392ED4AQ21116337-B93E4DCF-F061-4369-8926-BEE71B8537D4Q21118097-5EC3C2F7-A6FD-4C8D-AF1E-CECAE7EC9380Q21118889-D20AC18B-CC1D-4A41-A134-77B9F70F4CF0Q21119091-55A9C892-B606-4776-82B4-20B3C467588EQ21119477-765899B3-3715-4B70-AFA8-AADF45637CC1Q21132860-F330A291-77CF-4C61-8C6F-D7CA63B72DBAQ21133097-0076FFFC-D70A-44B5-AD71-3A7A2BA6E862Q21134401-9C82D411-1899-40ED-9A1D-5D989F2D3D16Q21145991-E72C28C1-84B9-4074-83AB-B47FD2F0D1E3Q21149662-0B8ECBE0-BF3A-44E2-A1AB-5EAC2F672201Q21154391-1DBE8D3D-6555-4B8E-BAF5-7995405E7F0FQ21174449-93B8152E-FE2C-4EC0-8356-B8F540D135CAQ21493890-1BE1BFEB-74AA-4481-A05F-37441FA7E905Q21494462-6B56619B-F4AD-46A1-9C17-B33E4C341FF8Q21494981-FE70293C-DB26-4EB3-A7B5-777B0D07F36BQ21495857-CC54B535-7688-4482-8097-7DEA5C8C3F95Q21496609-60A9C208-C476-4C62-AC4D-2201A783069CQ21981591-865D161B-C4A1-4D7F-9DF1-C2BF709CB43BQ21982542-69D1E6D5-8543-4843-A68D-7CB38C1EF97DQ21982557-E696E949-95A1-4048-9B58-C78025EA7D44Q21983998-0DC4CDF6-D6F1-46F1-B7E8-C39CB51B92A2Q21984242-330C39A6-8A74-448F-92A6-50F19446F483Q21984467-74685477-14E1-4112-99E3-42DD7650ACC6Q21985378-3310ACBB-AA66-4782-A38C-825E67178AC2Q21985896-507388F4-E28E-4888-92D5-8D3BD55E52CAQ21989439-CB3B5E28-7503-466A-B943-5E0F23ABEB07Q22678348-DB4A4D8D-A38F-4E10-A886-9A24FF986F97Q2639180-AA82748E-626D-4711-A1EE-6F3030325135Q28556229-C9362C60-3F34-4F55-9F31-548F0EB34FDE
P682
description
Any process that decreases the ...... ring one of the normal phases.
@en
biologisch proces
@nl
name
negative regulation of cell cycle arrest
@en
type
label
negative regulation of cell cycle arrest
@en
altLabel
GO:0071157
@en
prefLabel
negative regulation of cell cycle arrest
@en
P279
P279
P2888
P686
GO:0071157